secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001171520-22-000364
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro nullifies authorized share decrease after proxy statement error
--------------------------------------------------------------------------------

- At May 24, 2022 Annual Meeting, stockholders approved decreasing authorized shares from 200M to 80M.
- Beneficial owner questioned proxy statement inaccuracy on broker discretionary voting for the share decrease proposal.
- Company filed Certificate of Correction on June 3, 2022 to nullify the previously filed Certificate of Amendment.
- Company will seek stockholder approval again at a future meeting to achieve modest Delaware franchise tax savings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000364/0001171520-22-000364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000364/eps10300.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer